Seoul, South Korea

Suk Woo Choi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Snu Rdb Foundation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suk Woo Choi. Retrieved from https://idiyas.com/inventor/suk-woo-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suk Woo Choi: Innovator in Pharmaceutical Composition for Anxiety Disorders

Introduction

Suk Woo Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of anxiety disorders. His innovative work focuses on the use of N-acetyl-L-cysteine and its derivatives.

Latest Patents

Suk Woo Choi holds a patent for a pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorders. This patent addresses the treatment of conditions such as post-traumatic stress disorder and phobias. The composition is designed to block the renewal of fear memories when administered during or after exposure therapy.

Career Highlights

Choi is associated with the SNU RDB Foundation, where he continues to advance his research and development efforts. His work has the potential to significantly impact the treatment landscape for anxiety disorders.

Collaborations

Some of his notable coworkers include Bo Bae An and Beom Jong Song, who contribute to the collaborative efforts at the SNU RDB Foundation.

Conclusion

Suk Woo Choi's innovative approach to treating anxiety disorders through pharmaceutical compositions showcases his dedication to improving mental health treatments. His contributions are paving the way for new therapeutic options in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…